few days ago at Macroaxis 
By Ellen Johnson
Today I will analyze 5 Large Blend isntruments to have in your portfolio in February 2019. I will break down the following equities: Nuveen Symphony All Cap Core C, PowerShares SP Intl Dev Momentum ETF, Guggenheim SP 100 Equal Weight ETF, ChangeFinanceDivrsImpctUSLgCpFsslFlFrETF, and CatalystGroesbeck Growth of Income I
 thematic ideas   macroaxis
  few days ago at Macroaxis 
By Achuva Shats
This story covers 5 Disruptive Technologies isntruments to have in your portfolio in February 2019. Specifically, I will break down the following equities: Open Text Corporation, Workday, Ballard Power Systems, Ambarella, and Xilinx
 thematic ideas   macroaxis
Bellicum Pharmaceuticals
  few days ago at Macroaxis 
By Ellen Johnson
Is Bellicum Pharmaceuticals valuation justified? I will cover Bellicum Pharmaceuticals in this post to give you a better outlook on taking a position in this stock. What is Bellicum Pharmaceuticals Target Price Odds to finish over Current Price? Based on normal probability distribution, the odds of Bellicum Pharmaceuticals to move above current price in 30 days from now is about 82.02%. The Bellicum Pharmaceuticals probability density function shows the probability of Bellicum Pharmaceuticals Stock to fall within a particular range of prices over 30 days . Given the investment horizon of 30 days, Bellicum Pharmaceuticals has beta of -0.3534 . This suggests as returns on benchmark increase, returns on holding Bellicum Pharmaceuticals are expected to decrease at a much smaller rate. During bear market, however, Bellicum Pharmaceuticals is likely to outperform the market. Additionally Bellicum Pharmaceuticals has a negative alpha implying that the risk taken by holding this equity is not justified. The company is significantly underperforming S&P 500.
 valuation ideas   bellicum pharmaceuticals healthcare biotechnology pharmaceutical products
General Electric
  few days ago at Macroaxis 
By Ellen Johnson
This post will break down General Electric. I will look into why we are still optimistic in anticipation of a recovery. General Electric Piotroski F Score is 8 - Strong. What is General Electric Target Price Odds to finish over Current Price? Based on normal probability distribution, the odds of General Electric to move above current price in 30 days from now is about 11.83%. The General Electric Company probability density function shows the probability of General Electric Stock to fall within a particular range of prices over 30 days . Allowing for the 30-days total investment horizon, the stock has beta coefficient of 1.2133 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average . However, if the benchmark returns are expected to be negative, General Electric will likely underperform. Additionally General Electric Company has an alpha of 0.2163 implying that it can potentially generate 0.2163% excess return over S&P 500 after adjusting for the inherited market risk (beta).
 risk ideas   general electric industrials diversified industrials electrical equipment
Grupo Carso S
  few days ago at Macroaxis 
By Vlad Skutelnik
Grupo Carso chance of financial distress is about 26.0 percent. Grupo Carso S retains regular Real Value of 77.6817 per share. The prevalent price of the corporation is 75.61. At this time the corporation appears to be fairly valued. Macroaxis calculates value of Grupo Carso S from evaluating the corporation fundamentals such as Current Valuation of 160.83B, Return On Asset of 5.72% and Return On Equity of 14.89% as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we encourage to acquire undervalued assets and to sell overvalued assets since at some point stocks prices and their ongoing real values will come together.
 forecast ideas   grupo carso services department stores
  few days ago at Macroaxis 
By Achuva Shats
This story covers 4 Large Blend isntruments to have in your portfolio in February 2019. Specifically, I will break down the following equities: Nuveen Symphony All Cap Core C, PowerShares SP Intl Dev Momentum ETF, ChangeFinanceDivrsImpctUSLgCpFsslFlFrETF, and CatalystGroesbeck Growth of Income I
 thematic ideas   macroaxis
  few days ago at Macroaxis 
By Vlad Skutelnik
Today I will concentrate on 8 Chemicals Makers equities to hold on to in February 2019. I will cover Koninklijke DSM N V, Astec LifeSciences Limited, Asahi Kasei Corporation, Givaudan SA, Akzo Nobel N V, Evonik Industries AG, Shin Etsu Chemical Co Ltd, and DowDuPont
 thematic ideas   macroaxis
  few days ago at Macroaxis 
By Vlad Skutelnik
Today article will analyze 3 Energy equities to potentially sell in February 2019. I will specifically cover the following equities: UBS ETRACS Alerian MLPInfrs ETN SerB, Rydex Energy Services Inv, and Deutsche MLP Energy Infras Instl
 thematic ideas   macroaxis
Barclays PLC
  few days ago at Macroaxis 
By Achuva Shats
Here I will analyze some fundamental drivers that Barclays PLC investors should consider in February. Macroaxis considers Barclays PLC to be not too risky. Barclays PLC secures Sharpe Ratio (or Efficiency) of -0.3277 which signifies that Barclays PLC had -0.3277% of return per unit of risk over the last 1 month. Macroaxis philosophy towards foreseeing risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. Barclays PLC exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Barclays PLC Risk Adjusted Performance of (0.36) and Mean Deviation of 1.05 to double-check risk estimate we provide.
 product ideas   barclays plc financial services banks - global
Yakult Honsha
  few days ago at Macroaxis 
By Vlad Skutelnik
In this article I will break down Yakult Honsha. I will evaluate why we are still optimistic in anticipation of a recovery. Yakult Honsha elasticity to market is moves indifferently to market moves. We found thirty-two available indicators for Yakult Honsha which can be compared to its rivals. To make sure the equity is not overpriced, please check out all Yakult Honsha fundamentals including its Total Debt, Number of Employees and the relationship between Net Income and Book Value Per Share . Given that Yakult Honsha has Price to Book of 3.43X, we strongly advise you confirm Yakult Honsha prevalent market performance to make sure the company can sustain itself down the road. Use Yakult Honsha to protect your portfolios against small markets fluctuations. The stock experiences very speculative upward sentiment. Check odds of Yakult Honsha to be traded at $33.06 in 30 days.
 technicals ideas   yakult honsha consumer defensive beverages - soft drinks

Share Stories

Syndicate Stories to major social sites

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Did you try this?

Run Price Ceiling Movement Now

   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
All  Next Launch Price Ceiling Movement
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Find Alpha
Etf Screener
Evaluate and analyze market performance of ETFs against different fundamental indicators, sectors and families
Research ETFs
Insiders Directory
Find insiders across different sectors to evaluate their impact on performance and growth of their entities
Research Insiders
Search macroaxis.com